66207-08-7

Basic information

• Product Name: 1-CBZ-3,4-EPOXYPIPERIDINE
• Synonyms: CIS-3-CBZ-7-OXA-3-AZA-BICYCLO[4.1.0]HEPTANE;BENZYL 7-OXA-3-AZABICYCLO[4.1.0]HEPTANE-3-CARBOXYLATE;7-Oxa-3-azabicyclo[4.1.0]heptane-3-carboxylic acid, phenylMethyl ester;benzyl (1S,6R)-7-oxa-3-azabicyclo[4.1.0]heptane-3-carboxylate;N-Cbz-3,4-epoxypiperidine;1-CBZ-3,4-EPOXYPIPERIDINE
• CAS NO: 66207-08-7
• Molecular Formula: C₁₃H₁₅NO₃
• Molecular Weight: 233.266
• EINECS: -0
• Mol File: 66207-08-7.mol
• Article Data: 25

Chemical Properties

• Boiling Point: 368.4±35.0 °C(Predicted)
• Appearance: /
• Density: 1.256±0.06 g/cm3(Predicted)
• Refractive Index: 1.54
• PKA: -0.88±0.20(Predicted)
• CAS DataBase Reference: 1-CBZ-3,4-EPOXYPIPERIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 1-CBZ-3,4-EPOXYPIPERIDINE(66207-08-7)
• EPA Substance Registry System: 1-CBZ-3,4-EPOXYPIPERIDINE(66207-08-7)

Safety Data

• Hazardous Substances Data: 66207-08-7(Hazardous Substances Data)

Usage

General Description

1-CBZ-3,4-EPOXYPIPERIDINE is a chemical compound that consists of a piperidine ring with a carbamate (CBZ) group and an epoxide (3,4-epoxy) moiety. It is commonly used as a building block in organic synthesis and drug development. The epoxide functional group makes it a useful intermediate in the formation of various bioactive compounds, while the piperidine ring provides structural diversity and potential for interactions with biological targets. 1-CBZ-3,4-EPOXYPIPERIDINE has demonstrated potential applications in medicinal chemistry and pharmaceutical research, particularly in the design and synthesis of new drug candidates for various therapeutic indications. Additionally, 1-CBZ-3,4-EPOXYPIPERIDINE may also be utilized as a reagent in organic transformations to introduce the piperidine and epoxide functionalities into various organic molecules.

Upstream product

• 694-05-3 1,2,3,6-tetrahydropyridine 
• 501-53-1 benzyl chloroformate 
• 13139-17-8 N-(Benzyloxycarbonyloxy)succinimide 
• 75315-63-8 N-(benzyloxycarbonyl)succinimide 
• 174681-58-4 5,6-dihydropyridine-1(2H)-carboxylate 
• 937-14-4 3-chloro-benzenecarboperoxoic acid 
• 66207-23-6 1-benzyloxycarbonyl-1,2,3,6-tetrahydropyridine 

Downstream Products

• 161157-50-2 tert-butyl 7-oxa-3-azabicyclo[4.1.0]heptane-3-carboxylate 
• 859854-67-4 trans-benzyl 3-((tert-butoxycarbonyl)amino)-4-hydroxypiperidine-1-carboxylate 
• 444188-88-9 benzyl 3,7-diazabicyclo[4.1.0]heptane-3-carboxylate 
• 444188-89-0 7-(diethoxyphosphoryl)-3,7-diazabicyclo[4.1.0]heptane-3-carboxylic acid benzyl ester 
• 905281-83-6 benzyl 4-(4-bromo-3-(pyridin-4-yl)-1H-pyrazol-1-yl)piperidine-1-carboxylate 
• 1052715-50-0 C₁₉H₂₈N₂O₇S 
• 1052715-53-3 C₁₉H₂₄N₂O₆ 
• 1312789-31-3 (+/-)-benzyl 3-amino-4-hydroxypiperidine-1-carboxylate 
• 1052713-37-7 (3S,4S)-benzyl 3-(tert-butoxycarbonylamino)-4-(tert-butyldimethylsilyloxy)piperidine-1-carboxylate 
• 1620011-88-2 C₃₉H₅₄F₂N₆O₆SSi 
• 1620015-15-7 C₃₉H₅₄F₂N₆O₆SSi 
• 1620011-89-3 (3R,4R)-5-amino-N-{4-[3,4-trans-3-amino-4-hydroxypiperidin-1-yl]-6,7-dihydro-5H-cyclopenta[b]pyridin-3-yl}-2-(2,6-difluorophenyl)-1,3-thiazole-4-carboxamide 
• 1620015-18-0 C₃₄H₃₈F₂N₆O₇S 
• 1620015-17-9 (3R,5S)-5-amino-N-{4-[3,4-cis-3-amino-4-hydroxypiperidin-1-yl]-6,7-dihydro-5H-cyclopenta[b]pyridin-3-yl}-2-(2,6-difluorophenyl)-1,3-thiazole-4-carboxamide 

Relevant articles and documents

HETEROARYLDIHYDROPYRIMIDINE DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS

Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.

PROTEIN KINASE C INHIBITORS AND METHODS OF THEIR USE

PKC inhibitors are disclosed. The PKC inhibitors are useful for treating PKC associated diseases, including certain cancers. The PKC inhibitors have improved efficacy at lower dosage amounts to achieve tumor regression, improved potency, PK profile, absor

2-(AZAINDOL-2-YL)BENZIMIDAZOLES AS PAD4 INHIBITORS

Compounds of formula (I): wherein; R1 is hydrogen or C1-6alkyl;R2 is hydrogen, C1-6alkyl, perhalomethylC0-5alkyl-O—, or C1-6alkoxy;R3 is hydrogen, C1-6alkyl, or C1-6alkoxyC1-6alkyl;R4 is hydrogen, C1-6alkyl, perhalomethylC1-6alkyl; or unsubstituted C3-6cycloalkylC1-6 alkyl;A is C—R5 or N;B is C—R6 or N;D is C—R7 or N;with the proviso that at least one of A, B, and D, is N;R5 is hydrogen or C1-6alkyl;R6 is hydrogen or C1-6alkyl;R7 is hydrogen, C1-6alkyl, C1-6alkoxy, or hydroxy;R8 is hydrogen or C1-6alkyl, with the proviso that one of R4 and R8 is hydrogen;R9 is hydrogen or hydroxy;R10 is hydrogen or C1-6alkyl; and salts thereof are PAD4 inhibitors and may be useful in the treatment of various disorders, for example rheumatoid arthritis, vasculitis, systemic lupus erythematosus, ulcerative colitis, cancer, cystic fibrosis, asthma, cutaneous lupus erythematosis, and psoriasis.